Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance.

Rachel Hayden, Guy Pratt, Mark Drayson, Christopher Bunce

Research output: Contribution to journalArticle

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance.'. Together they form a unique fingerprint.

Medicine & Life Sciences